SCHEMBL27410375

SCHEMBL27410375

CCNC(=O)C(C)(N)CO

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
KMT2A Q03164 1/20 0.32
MCL1 Q07820 1/20 0.31
FAAH O00519 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2297020 0.78
SCHEMBL25962152 0.77 MMP1 (0.30) MMP1MMP2MMP3MMP9MMP8
SCHEMBL28860724 0.76
SCHEMBL21661357 0.76
Hydrochloric Acid SCHEMBL7447733 0.76 MMP1 (0.36) MMP1MMP2MMP3MMP9MMP8
SCHEMBL13687263 0.76 RIPK1 (0.37) MMP1MMP2MMP3MMP9MMP8
Hydrochloric Acid SCHEMBL31604845 0.74 GGT1 (0.30)
SCHEMBL24543403 0.74 EPHX1 (0.38) KMT2A
SCHEMBL1346149 0.72
SCHEMBL20648929 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024100139-A1 USE OF IFN-I ACTIVITY AS A BIOMARKER FOR TLR INHIBITOR TREATMENT MERCK PATENT GMBH (DE) 2024-05-16 WO disclosed